Medical Journals

Long-term Wash-resistant Effects of Brief Interaction of Xanomeline at the M1 Muscarinic Receptor.

Authors:
  • De Lorme Kayla C
  • Sikorski Krista L
  • Grant Marianne K O
  • El-Fakahany Esam E

From: Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Mayo Mail Code 392, 420 Delaware St. SE, Minneapolis, MN 55455, USA.

Neuroscience letters

  • Publish Date: Dec 2006
  • ISSN: 0304-3940
  • Volume: 410
  • Issue: 1
  • Pages: 11-4
  • Medium: Print
  • Language: English
  • Citation (JAMA): De Lorme Kayla C, Sikorski Krista L, Grant Marianne K O, et al. Long-term Wash-resistant Effects of Brief Interaction of Xanomeline at the M1 Muscarinic Receptor.. Neurosci. Lett. Dec 2006;410:11-4

Abstract

Compared to other M(1) muscarinic acetylcholine receptor (M(1) mAChR) agonists, xanomeline demonstrates both reversible and persistent modes of binding to the receptor. In our study, we investigated the long-term consequences of brief incubation of Chinese hamster ovary cells expressing M(1) mAChR (M(1)-CHO) with low concentrations of xanomeline followed by washing off the free drug. Thus, M(1)-CHO cells were exposed to 100 nM xanomeline for 1h then washed extensively. Washed cells were either used immediately for binding assays or incubated for 23 h in the absence of free xanomeline. Only the latter treatment conditions resulted in marked attenuation of binding of the muscarinic radioligand [(3)H]N-methylscopolamine ([(3)H]NMS) to intact cells. Shortening the xanomeline pretreatment period to 1 min had the same trends as the 1h pretreatment, implying that xanomeline binds instantly to the receptor to elicit long-term wash-resistant effects. Presence of atropine during the brief period of xanomeline pretreatment did not markedly modulate xanomeline’s long-term effects, which suggests that persistent anchoring of the xanomeline molecule to the M(1) receptor takes place at a site distinct from the orthosteric binding domain. Our findings suggest the possibility of a time-dependent transition of the conformation of the muscarinic M(1) receptor-xanomeline complex between states that vary in their ability to bind [(3)H]NMS. However, possible involvement of other mechanisms of long-term receptor regulation cannot be discounted.

Mesh Headings (Keywords): Animals, Atropine, Binding, Competitive, CHO Cells, Cricetinae, Cricetulus, Drug Interactions, Humans, Muscarinic Agonists, Muscarinic Antagonists, N-Methylscopolamine, Pyridines, Receptor, Muscarinic M1, Thiadiazoles, Time Factors, Transfection, Tritium


Check for Full Text / PubMed Unique Identifier (PMID): 17052840


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.